ALTERED FRACTIONATION RADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCERS; A REVIEW

Authors

  • Thiti Swangsilpa
  • Pramook Phromratanapongse
  • Ketkamol Punkosol

Abstract

Altered fractionation radiotherapy has been used to treat locally advanced head and neck cancers for many years. There are 3 types of altered fractionation; a) hyperfractionation b) accelerated fractionation, which is divided into 4 subtypes, and c) chemoacceleration. This paper is a review of the results of phase I, II, III clinical trials in each type of altered fractionation radiotherapy in locally advanced head and neck cancers. The ongoing protocol study of current EORTC and RTOG trials are also shown.

References

Ang KK, Thames HD, Peter LJ. Altered fractionation schedules. In : Perez CA, Brady LW. eds Principles and Practice of Radiation Oncology 3** Ed. Philadelphia: Lippincott Raven 1997; 119-42.

Shukovsky LJ,Fletcher GH,Montaque ED, Whithers HR. Experience with twice-a-day fractionation in clinical radiotherapy. Am J Roentgenol 1976; 126: 155-61.

Jampolis S,Pipard G, Hariot JC,Bolla M, Le-Dorze C. Preliminary results using twice-a-day fractionation in the radiotherapeutic management of advanced cancers of the head and neck. Am J Roentgenol 1977; 129: 1091-3.

Median E, Rao Y, Kim T, Levitt SH. Radiation therapy for advanced head and neck squamous cell carcinoma using twice-a-day fractionation, a long term follow-up. Am J Clin Oncol 1985; 8:65-8.

Horiot JC, Nabid A, Chaplain G et al. Clinical experience with multiple daily fractionation in the radiotherapy of head and neck carcinoma. Cancer Bull 1982; 34 :230-3.

Meoz RT, Fletcher GH, Peters LJ, Barkley HT, Thames HD. Twice-daily fractionation schemes for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1984; 10:831-6.

Parsons IT, Cassisi NJ, Million RR. Results of twice-a-day irradiation of squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 1984; 10: 2041-51.

Parsons JT, Mendenhall WM, Cassisi NJ, Isaacs JH Jr, Million RR. Hyperfractionation for head and neck cancer. Int I Radiat Oncol Biol Phys 1988; 14:649-58.

Parsons JT,Mendenhall WM, Stringer SP, et al: Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience. Head neck 1993; 87-96.

Cox JD, Pajak TF,Marcial VA, et al. Dose-response For local control with hyperfractionated radiotherapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of Radiation Therapy Oncology Group protocal 8313. Int J Radiat Oncol Biol Phys 1991; 20:1191-5.

Cox JD, Pajak TF, Marical VA, et al. ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts : results from Radiation Therapy Oncology Group protocal 8313. Int J Radiat Oncol Biol Phys 1991; 20 : 1191-5.

Marcial VA, Pajak TF, Chang C, Tupchong L, Stetz J. Hyperfractionated proton radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys; 13:41-7.

Harriot JC, Van Den Bogaert, Ang KK et al. European Organization For Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day: a 1978-1987 survey. Front Radiat Ther Oncol 1988; 22: 149-61.

Datta NR, Choudhry AD, Gupta S. Twice a day versus once a day radiation therapy in head and neck cancer. Int J Radiat Oncol Biol Phys 1989; 17:132-3.

Sanchi'z F, Milla' A, Torner J, et al. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys. 1990; 1347-50.

Pinto L, Canary P, Aranjo C, et al: Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stage II and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991; 21: 557-62.

Horiot IC, Le Fun R, N' Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992; 25: 231-41.

Peracchia G, Salti C. Radiotherapy with twice-a-day fractionation in a short overall time: Clinical experiences. Int J Radiat Oncol Biol Phys 1981; 7:99.

Svoboda V. Accelerated fractionation. The Portsmouth experience 1971-1984. In Proceeding of Varian's Fourth European (Linac Users Meeting) Malta, May 25-26, 1984. Zug, Switzerland, Varian, 1984:70.

Olmi P, Cellai E, Chiavacci A Fallai C. Accelerated fractionation in advanced head and neck cancer: Results and analysis of late sequelae. Radiother Oncol; 17 : 199-207.

Lamb Ds, Spry NA, Gray AJ,Johnson AD, Alexander SR, Dally MJ. Accelerated fractionated radiotherapy for advanced head and neck cancer. Radiation Oncol 1990; 18: 107-116.

Saunders MI, Dische S, Grosch EJ, et al. Experience with CHART. Int J Radiat Oncol Biol Phys 1991; 21: 871-8.

Awwad HK, Khafagy, Barsoum M, et al. Accelerated versus convention in the postoperative radiation of locally advanced head and neck cancer: influence of tumor proliferation. Radiother Oncol 1992; 25: 261-6.

Dische S, Saunders M, Barrett A, et al. A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997; 44 : 123-36.

Withers RH. Overview of fractionation schedules for cancer of the head and neck. Proceeding ASTRO 39** 1997; 12.

Wang CC, Blitzer PH, Suit HD. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985; 55: 2100-4.

Wang CC. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int J Radiat Oncol Biol Phys 1988; 14: 1143-6.

Wang CC, Efird J, Nakfoor B, Martins P. Local control of T. carcinomas after accelerated fractionation: A look at the "gap". Int J Radiat Oncol Phys 1995; 32 (Suppl 1): 162.

Wang CC, Efird J, Nakfoor B, Martins P. Local control of T. carcinomas after accelerated fractionation: A look at the "gap". Int J Radiat Oncol Phys 1996; 35: 439-41.

Horiot JC, Bontemps P, van den Bogaert W, et al. Accelerated fractionation compared to conventional fractionation improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997; 44: 111-21.

Knee R, Fields RS, Peters LJ. Concomitant boost radiotherapy for advanced squamous cell of the head and neck. Radiother Oncol 1985; 4:1-7.

Kaanders J, van Daal WJ, Hoogenraad W, et al. Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity. Int J Radiat Oncol Biol Phys 1992; 24: 497-503.

Mak AC, Morrison WH, Garden AS, et al. Base-of-tonque carcinoma: treatment results using concomitant boost radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33: 289-96.

Gwozdz IT Morrison WH, Garden AS, et al. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys 1997; 39: 127-35.

Ang KK, Peters LJ, Weber RS, et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharymx and nasopharynx. Int J Radiay Oncol Biol Phys 1990; 19: 1339-45.

Ang KK, Peters LJ. Concomitant boost radiotherapy in the treatment of head and neck cancer. Semin Radiat Oncol 1992; 2:31.

Schmidt-Ullrich RK, Johnson CR, Wazen DE, et al. Accelerated superfractionated irradiation for advanced carcinoma of the head and neck : concomitant boost technique. Int J Radiat Oncol Biol Phys 1991; 21: 563-8.

Johnson CR, Schmidt-Ullrich RK, Arther DW, et al. Standard once-daily versus twice-daily concomitant boost accelerated superfractionated irradiation for advanced squamous cell carcinoma of the head and neck: preliminary results of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1995; 32( Suppl 1): 162.

Fu KK, Clery M, Ang KK et al. Randomized phase I, II trial of two variants of accerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Int I Radiat Oncol Biol Phys 1995; 32: 589-97.

Schwade J, Morhoe A, Abitbol A. Accelerating hyperfractionation for carcinoma of the head and neck. Semin Radiat Oncol, 1992; 2:51.

Harari PM. Adding dose escalation to accelerated hyperfractionation for head and neck cancer. Semin Radiat Oncol 1992, 2:58.

Kajanti M, Blomqvist C, Lehtoneh H, Kouri M, Wiklund T, Holsti LR. Biweekly dose escalation in curative accelerated hyperfractionation for advanced head and neck cancer: a feasibility study. Int J Rad Oncol Biol Phys 1997, 39: 837-40.

Harrison LB, Prister DG, Fars DE, et al. Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 1991, 21; 703-8.

Frontanesi J, Beck for NS, Lester EP, et al. Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neck. Am J Surg 1991, 162: 393-6.

Abitbol AA, Schwade JG, Lewin AA et al. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. Am J Clin Oncol 1992, 15: 250-5.

Brizel DM, Leopold KA, Fisher SR, et al. A phase I,II trial of twice daily irration and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1994, 28; 213-20.

Arias F Dominguez MA, Illarramendi Jj, et al. Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report. Int J Radiat Oncol Biol Phys 1995, 33:675-82.

Glicksman AS, Wanebo HJ, Slotman G, et al. Concurrent platinum-based chemotherapy and hyperfractioned radiotherapy with late intensification in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1997, 39: 721-9.

Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl Med 19998, 338: 1798-804.

Withers RH. Overview of fractionation schedules for cancer of the head and neck. Proceeding ASTRO 39* 1997; 8.

Fu KK, Cooper Js, Marcial VA, et al. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer. Int J Radiat Oncol Biol Phys 1996, 35: 425-38.

Downloads

Published

2025-03-07

How to Cite

1.
Swangsilpa T, Phromratanapongse P, Punkosol K. ALTERED FRACTIONATION RADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCERS; A REVIEW. J Thai Assn of Radiat Oncol [internet]. 2025 Mar. 7 [cited 2025 Dec. 26];4(3):12-24. available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/277829

Issue

Vol. 4 No. 3 (1998): September - December

Section

Original articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารมะเร็งวิวัฒน์ สมาคมรังสีรักษาและมะเร็งวิทยาแห่งประเทศไทย

ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับสมาคมรังสีรักษาและมะเร็งวิทยาแห่งประเทศไทย และบุคคลากรท่านอื่น ๆ ใน สมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใดๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว